Inflammatory responses bridge comorbid cardiac disorder in experimental model of IBD induced by DSS: protective effect of the trigonelline

  • Hossein Omidi-Ardali
  • Zahra Lorigooini
  • Amin Soltani
  • Shima Balali-Dehkordi
  • Hossein Amini-KhoeiEmail author
Original Article


Pathogenesis of the inflammatory bowel disease (IBD) involves the combination of immunological and inflammatory factors. IBD is associated with several extra-intestinal manifestations. The exact underlying bridge between the probable cardiac diseases in IBD patients is undetermined. Trigonelline is an alkaloid with several therapeutic potential properties. In this study, we aimed to assess the probable underlying mechanisms of this comorbidity as well as protective effect of trigonelline focusing inflammatory response and oxidative state in mouse model of colitis. Dextran sodium sulfate (DSS) was used for induction of colitis in mice. Trigonelline (10, 50 and 100 mg/kg) was administrated via intraperitoneal rout (i.p.) for 14 continuous days. Heart, intestine and serum samples were taken for assessment of total antioxidant capacity, malondialdehyde (MDA), gene expressions of inflammatory markers including tumor necrosis factor alpha (Tnf-α), interleukin 1-beta (Il/1β), toll- like receptor 4 (Tlr4) as well as for evaluation of histopathological alterations. Results demonstrated that trigonelline effectively attenuated the cellular/molecular and histopathological adverse effects of colitis in the intestine and heart tissues. In this regards, we found that trigonelline decreased the MDA level, attenuated the expression of Tnf-α, Il/1β and, Tlr4 as well as modulated the histopathological alterations in the intestine. Furthermore, trigonelline increased the antioxidant capacity in the related experimental groups. We concluded that IBD (colitis) is associated with comorbid cellular/molecular modifications in the heart and for the first time, we found that trigonelline has potential therapeutic effects (at least partially) to attenuate the cardiac manifestations of the colitis.


Inflammatory bowel disease Cardiac complications Comorbidity Trigonelline Mice 



This work was supported by a grant from Shahrekord University of Medical Sciences (SKUMS) with grant number of “2363”. The authors would like to thank Dr. Mahmoud Rafieian kopaei, Dr. Gholam Reza Mobini, Dr. Elham Saghaei and Mrs. Elham Bijad for their collaboration on this study.


  1. Al-Sadi RM, Ma TY (2007) IL-1β causes an increase in intestinal epithelial tight junction permeability. J Immunol 178:4641–4649CrossRefGoogle Scholar
  2. Amini-Khoei H, Momeny M, Abdollahi A, Dehpour AR, Amiri S, Haj-Mirzaian A, Tavangar SM, Ghaffari SH, Rahimian R, Mehr SE (2016) Tropisetron suppresses colitis-associated cancer in a mouse model in the remission stage. Int Immunopharmacol 36:9–16CrossRefGoogle Scholar
  3. Amini-Khoei H, Haghani-Samani E, Beigi M, Soltani A, Mobini GR, Balali-Dehkordi S, Haj-Mirzaian A, Rafieian-Kopaei M, Alizadeh A, Hojjati MR (2019) On the role of corticosterone in behavioral disorders, microbiota composition alteration and neuroimmune response in adult male mice subjected to maternal separation stress. Int Immunopharmacol 66:242–250CrossRefGoogle Scholar
  4. Antoni L, Nuding S, Wehkamp J, Stange EF (2014) Intestinal barrier in inflammatory bowel disease. World J Gastroenterol 20:1165CrossRefGoogle Scholar
  5. Antonisamy P, Arasu MV, Dhanasekaran M, Choi KC, Aravinthan A, Kim NS, Kang C-W, Kim J-H (2016) Protective effects of trigonelline against indomethacin-induced gastric ulcer in rats and potential underlying mechanisms. Food Funct 7:398–408CrossRefGoogle Scholar
  6. Arlt A, Sebens S, Krebs S, Geismann C, Grossmann M, Kruse M, Schreiber S, Schäfer H (2013) Inhibition of the Nrf2 transcription factor by the alkaloid trigonelline renders pancreatic cancer cells more susceptible to apoptosis through decreased proteasomal gene expression and proteasome activity. Oncogene 32:4825CrossRefGoogle Scholar
  7. Blumberg RS, Strober W (2001) Prospects for research in inflammatory bowel disease. JAMA 285:643–647CrossRefGoogle Scholar
  8. Bouma G, Strober W (2003) The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 3:521CrossRefGoogle Scholar
  9. Cardozo LF, Pedruzzi LM, Stenvinkel P, Stockler-Pinto MB, Daleprane JB, Leite M Jr., Mafra D (2013) Nutritional strategies to modulate inflammation and oxidative stress pathways via activation of the master antioxidant switch Nrf2. Biochimie 95:1525–1533CrossRefGoogle Scholar
  10. Danese S, Semeraro S, Papa A, Roberto I, Scaldaferri F, Fedeli G, Gasbarrini G, Gasbarrini A (2005) Extraintestinal manifestations in inflammatory bowel disease. World J Gastroenterol 11:7227CrossRefGoogle Scholar
  11. Dutta M, Ghosh AK, Mohan V, Mishra P, Rangari V, Chattopadhyay A, Das T, Bhowmick D, Bandyopadhyay D (2014) Antioxidant mechanism (s) of protective effects of Fenugreek 4-hydroxyisoleucine and trigonelline enriched fraction [TF4H (28%)] Sugaheal® against copper-ascorbate induced injury to goat cardiac mitochondria in vitro. J Pharm Res 8:798–811Google Scholar
  12. Gabriels K, Hoving S, Seemann I, Visser NL, Gijbels MJ, Pol JF, Daemen MJ, Stewart FA, Heeneman S (2012) Local heart irradiation of ApoE−/− mice induces microvascular and endocardial damage and accelerates coronary atherosclerosis. Radiother Oncol 105:358–364CrossRefGoogle Scholar
  13. Gaur V, Bodhankar SL, Mohan V, Thakurdesai PA (2013) Neurobehavioral assessment of hydroalcoholic extract of Trigonella foenum-graecum seeds in rodent models of Parkinson’s disease. Pharm Biol 51:550–557CrossRefGoogle Scholar
  14. Haj-Mirzaian A, Amiri S, Amini-Khoei H, Hosseini M-J, Haj-Mirzaian A, Momeny M, Rahimi-Balaei M, Dehpour AR (2017) Anxiety-and depressive-like behaviors are associated with altered hippocampal energy and inflammatory status in a mouse model of Crohn’s disease. Neuroscience 366:124–137CrossRefGoogle Scholar
  15. Kojouharoff G, Hans W, Obermeier F, Männel D, Andus T, Schölmerich J, Gross V, Falk W (1997) Neutralization of tumour necrosis factor (TNF) but not of IL-1 reduces inflammation in chronic dextran sulphate sodium-induced colitis in mice. Clin Exp Immunol 107:353–358CrossRefGoogle Scholar
  16. Kristensen SL, Ahlehoff O, Lindhardsen J, Erichsen R, Lamberts M, Khalid U, Nielsen OH, Torp-Pedersen C, Gislason GH, Hansen PR (2014) Inflammatory bowel disease is associated with an increased risk of hospitalization for heart failure: a Danish Nationwide Cohort Study. Circ Heart Fail 7:717–722CrossRefGoogle Scholar
  17. Laird MH, Rhee SH, Perkins DJ, Medvedev AE, Piao W, Fenton MJ, Vogel SN (2009) TLR4/MyD88/PI3K interactions regulate TLR4 signaling. J Leukoc Biol 85:966–977CrossRefGoogle Scholar
  18. Liu L, Miao M, Chen Y, Wang Z, Sun B, Liu X (2018) Altered function and expression of abc transporters at the blood-brain barrier and increased brain distribution of phenobarbital in acute liver failure mice. Front Pharmacol 9:190CrossRefGoogle Scholar
  19. Luque-Sierra A, Alvarez-Amor L, Kleemann R, Martín F, Varela LM (2018) Extra-virgin olive oil with natural phenolic content exerts an anti-inflammatory effect in adipose tissue and attenuates the severity of atherosclerotic lesions in ldlr–/–.Leiden Mice. Mol Nutr Food Res 62:1800295CrossRefGoogle Scholar
  20. McKenzie S, Baker M, Buffinton G, Doe W (1996) Evidence of oxidant-induced injury to epithelial cells during inflammatory bowel disease. J Clin Investig 98:136–141CrossRefGoogle Scholar
  21. Menconi A, Hernandez-Velasco X, Vicuna E, Kuttappan V, Faulkner O, Tellez G, Hargis B, Bielke L (2015) Histopathological and morphometric changes induced by a dextran sodium sulfate (DSS) model in broilers. Poult Sci 94:906–911CrossRefGoogle Scholar
  22. Mirzaie M, Khalili M, Kiasalari Z, Roghani M (2016) Neuroprotective and antiapoptotic potential of trigonelline in a striatal 6-hydroxydopamine rat model of Parkinson’s disease. Neurophysiology 48:176–183CrossRefGoogle Scholar
  23. Nyska A, Murphy E, Foley JF, Collins BJ, Petranka J, Howden R, Hanlon P, Dunnick JK (2004) Acute hemorrhagic myocardial necrosis and sudden death of rats exposed to a combination of ephedrine and caffeine. Toxicol Sci 83:388–396CrossRefGoogle Scholar
  24. Pavli P, Cavanaugh J, Grimm M (1996) Inflammatory bowel disease: germs or genes? Lancet 347:1198CrossRefGoogle Scholar
  25. Popivanova BK, Kitamura K, Wu Y, Kondo T, Kagaya T, Kaneko S, Oshima M, Fujii C, Mukaida N (2008) Blocking TNF-α in mice reduces colorectal carcinogenesis associated with chronic colitis. J Clin Investig 118:560–570Google Scholar
  26. Rahnama S, Rabiei Z, Alibabaei Z, Mokhtari S, Rafieian-Kopaei M, Deris F (2015) Anti-amnesic activity of Citrus aurantium flowers extract against scopolamine-induced memory impairments in rats. Neurol Sci 36:553–560CrossRefGoogle Scholar
  27. Roifman I, Beck PL, Anderson TJ, Eisenberg MJ, Genest J (2011) Chronic inflammatory diseases and cardiovascular risk: a systematic review. Can J Cardiol 27:174–182CrossRefGoogle Scholar
  28. Schicho R, Marsche G, Storr M (2015) Cardiovascular complications in inflammatory bowel disease. Curr Drug Targets 16:181–188CrossRefGoogle Scholar
  29. Swidsinski A, Loening-Baucke V, Lochs H, Hale LP (2005) Spatial organization of bacterial flora in normal and inflamed intestine: a fluorescence in situ hybridization study in mice. World J Gastroenterol 11:1131CrossRefGoogle Scholar
  30. Thapa SD, Hadid H, Imam W, Schairer J, Jafri S-M (2015) Effect of inflammatory bowel disease-related characteristics and treatment interventions on cardiovascular disease incidence. Am J Med Sci 350:175–180CrossRefGoogle Scholar
  31. Tohda C, Kuboyama T, Komatsu K (2005) Search for natural products related to regeneration of the neuronal network. Neurosignals 14:34–45CrossRefGoogle Scholar
  32. Vicente SJ, Ishimoto EY, Torres EA (2013) Coffee modulates transcription factor Nrf2 and highly increases the activity of antioxidant enzymes in rats. J Agric Food Chem 62:116–122CrossRefGoogle Scholar
  33. Wong S, Knight J, Hopfer S, Zaharia O, Leach CN, Sunderman F (1987) Lipoperoxides in plasma as measured by liquid-chromatographic separation of malondialdehyde-thiobarbituric acid adduct. Clin Chem 33:214–220Google Scholar
  34. Xavier R, Podolsky D (2007) Unravelling the pathogenesis of inflammatory bowel disease. Nature 448:427CrossRefGoogle Scholar
  35. Yazbeck R, Howarth GS, Butler RN, Geier MS, Abbott CA (2011) Biochemical and histological changes in the small intestine of mice with dextran sulfate sodium colitis. J Cell Physiol 226:3219–3224CrossRefGoogle Scholar
  36. Yoshinari O, Takenake A, Igarashi K (2013) Trigonelline ameliorates oxidative stress in type 2 diabetic Goto-Kakizaki rats. J Med Food 16:34–41CrossRefGoogle Scholar
  37. Zhang H, Wang H-Y, Bassel-Duby R, Maass DL, Johnston WE, Horton JW, Tao W (2007) Role of interleukin-6 in cardiac inflammation and dysfunction after burn complicated by sepsis. Am J Physiol Heart Circ Physiol 292:H2408–H2416CrossRefGoogle Scholar
  38. Zhou J, Chan L, Zhou S (2012) Trigonelline: a plant alkaloid with therapeutic potential for diabetes and central nervous system disease. Curr Med Chem 19:3523–3531CrossRefGoogle Scholar
  39. Zhou J-Y, Du X-H, Zhang Z, Qian G-S (2017) Trigonelline inhibits inflammation and protects β cells to prevent fetal growth restriction during pregnancy in a mouse model of diabetes. Pharmacology 100:209–217CrossRefGoogle Scholar
  40. Zou L, Wang W, Liu S, Zhao X, Lyv Y, Du C, Su X, Geng B, Xu G (2016) Spontaneous hypertension occurs with adipose tissue dysfunction in perilipin-1 null mice. Biochim Biophys Acta (BBA) Mol Basis Dis 1862:182–191CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Medical Plants Research Center, Basic Health Sciences InstituteShahrekord University of Medical SciencesShahrekordIran
  2. 2.Department of Basic Sciences, Faculty of Veterinary MedicineShahid Chamran University of AhvazAhvazIran

Personalised recommendations